PubMed

The effect of intensive diabetes treatment on resting heart rate in type 1 diabetes: the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications study.

Paterson AD, Rutledge BN, Cleary PA, Lachin JM, Crow RS; Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group.

Diabetes Care. 2007 Aug;30(8):2107-12. Epub 2007 Apr 27.PMID: 17468351 [PubMed - indexed for MEDLINE]Related articlesFree article

Epidemiology of Diabetes Interventions and Complications (EDIC). Design, implementation, and preliminary results of a long-term follow-up of the Diabetes Control and Complications Trial cohort.

[No authors listed]

Diabetes Care. 1999 Jan;22(1):99-111.PMID: 10333910 [PubMed - indexed for MEDLINE]Related articlesFree article

Sustained effect of intensive treatment of type 1 diabetes mellitus on development and progression of diabetic nephropathy: the Epidemiology of Diabetes Interventions and Complications (EDIC) study.

Writing Team for the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group.

JAMA. 2003 Oct 22;290(16):2159-67.PMID: 14570951 [PubMed - indexed for MEDLINE]Related articlesFree article

The effect of intensive glycemic treatment on coronary artery calcification in type 1 diabetic participants of the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study.

Cleary PA, Orchard TJ, Genuth S, Wong ND, Detrano R, Backlund JY, Zinman B, Jacobson A, Sun W, Lachin JM, Nathan DM; DCCT/EDIC Research Group.

Diabetes. 2006 Dec;55(12):3556-65.PMID: 17130504 [PubMed - indexed for MEDLINE]Related articlesFree article

Prolonged effect of intensive therapy on the risk of retinopathy complications in patients with type 1 diabetes mellitus: 10 years after the Diabetes Control and Complications Trial.

White NH, Sun W, Cleary PA, Danis RP, Davis MD, Hainsworth DP, Hubbard LD, Lachin JM, Nathan DM.

Arch Ophthalmol. 2008 Dec;126(12):1707-15.PMID: 19064853 [PubMed - indexed for MEDLINE]Related articlesFree article

Beneficial effects of intensive therapy of diabetes during adolescence: outcomes after the conclusion of the Diabetes Control and Complications Trial (DCCT).

White NH, Cleary PA, Dahms W, Goldstein D, Malone J, Tamborlane WV; Diabetes Control and Complications Trial (DCCT)/Epidemiology of Diabetes Interventions and Complications (EDIC) Research Group.

J Pediatr. 2001 Dec;139(6):804-12.PMID: 11743505 [PubMed - indexed for MEDLINE]Related articles

Effect of intensive glycemic control on levels of markers of inflammation in type 1 diabetes mellitus in the diabetes control and complications trial.

Schaumberg DA, Glynn RJ, Jenkins AJ, Lyons TJ, Rifai N, Manson JE, Ridker PM, Nathan DM.

Circulation. 2005 May 17;111(19):2446-53. Epub 2005 May 2.PMID: 15867184 [PubMed - indexed for MEDLINE]Related articlesFree article

Effect of intensive diabetes treatment on carotid artery wall thickness in the epidemiology of diabetes interventions and complications. Epidemiology of Diabetes Interventions and Complications (EDIC) Research Group.

[No authors listed]

Diabetes. 1999 Feb;48(2):383-90.PMID: 10334318 [PubMed - indexed for MEDLINE]Related articlesFree article

Effect of intensive therapy on the microvascular complications of type 1 diabetes mellitus.

Writing Team for the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group.

JAMA. 2002 May 15;287(19):2563-9.PMID: 12020338 [PubMed - indexed for MEDLINE]Related articlesFree article

Effect of intensive therapy on residual beta-cell function in patients with type 1 diabetes in the diabetes control and complications trial. A randomized, controlled trial. The Diabetes Control and Complications Trial Research Group.

[No authors listed]

Ann Intern Med. 1998 Apr 1;128(7):517-23.PMID: 9518395 [PubMed - indexed for MEDLINE]Related articlesFree article

Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy. The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group.

[No authors listed]

N Engl J Med. 2000 Feb 10;342(6):381-9. Erratum in: N Engl J Med 2000 May 4;342(18):1376. PMID: 10666428 [PubMed - indexed for MEDLINE]Related articlesFree article

Effect of pregnancy on microvascular complications in the diabetes control and complications trial. The Diabetes Control and Complications Trial Research Group.

Diabetes Control and Complications Trial Research Group.

Diabetes Care. 2000 Aug;23(8):1084-91.PMID: 10937502 [PubMed - indexed for MEDLINE]Related articlesFree article

QTc interval and resting heart rate as long-term predictors of mortality in type 1 and type 2 diabetes mellitus: a 23-year follow-up.

Stettler C, Bearth A, Allemann S, Zwahlen M, Zanchin L, Deplazes M, Christ ER, Teuscher A, Diem P.

Diabetologia. 2007 Jan;50(1):186-94. Epub 2006 Nov 10.PMID: 17096116 [PubMed - indexed for MEDLINE]Related articles

Insights from the diabetes control and complications trial/epidemiology of diabetes interventions and complications study on the use of intensive glycemic treatment to reduce the risk of complications of type 1 diabetes.

Genuth S.

Endocr Pract. 2006 Jan-Feb;12 Suppl 1:34-41. Review.PMID: 16627378 [PubMed - indexed for MEDLINE]Related articles

Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes.

Nathan DM, Cleary PA, Backlund JY, Genuth SM, Lachin JM, Orchard TJ, Raskin P, Zinman B; Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study Research Group.

N Engl J Med. 2005 Dec 22;353(25):2643-53.PMID: 16371630 [PubMed - indexed for MEDLINE]Related articlesFree article

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.

[No authors listed]

Lancet. 1998 Sep 12;352(9131):837-53. Erratum in: Lancet 1999 Aug 14;354(9178):602. PMID: 9742976 [PubMed - indexed for MEDLINE]Related articles

The absence of a glycemic threshold for the development of long-term complications: the perspective of the Diabetes Control and Complications Trial.

[No authors listed]

Diabetes. 1996 Oct;45(10):1289-98.PMID: 8826962 [PubMed - indexed for MEDLINE]Related articles

Neuropathy among the diabetes control and complications trial cohort 8 years after trial completion.

Martin CL, Albers J, Herman WH, Cleary P, Waberski B, Greene DA, Stevens MJ, Feldman EL; DCCT/EDIC Research Group.

Diabetes Care. 2006 Feb;29(2):340-4.PMID: 16443884 [PubMed - indexed for MEDLINE]Related articlesFree article

Modern-day clinical course of type 1 diabetes mellitus after 30 years' duration: the diabetes control and complications trial/epidemiology of diabetes interventions and complications and Pittsburgh epidemiology of diabetes complications experience (1983-2005).

Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Research Group, Nathan DM, Zinman B, Cleary PA, Backlund JY, Genuth S, Miller R, Orchard TJ.

Arch Intern Med. 2009 Jul 27;169(14):1307-16.PMID: 19636033 [PubMed - indexed for MEDLINE]Related articles

Exogenous insulin administration and cardiovascular risk in non-insulin-dependent and insulin-dependent diabetes mellitus.

Genuth S.

Ann Intern Med. 1996 Jan 1;124(1 Pt 2):104-9.PMID: 8554200 [PubMed - indexed for MEDLINE]Related articles